We are international
Donate
TEXT SIZE   


ASCO 2012: Dr. Kumar - Weekly dosing of the investigational oral proteasome inhibitor MLN9708 in patients with relapsed/refractory multiple myeloma: A phase I study
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles